Journal info
|
||
Select Journal
Journals
Acta Virologica Bratislava Medical Journal Endocrine Regulations General Physiology and Biophysics Neoplasma Ahead of print 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 Studia Psychologica Cardiology Letters Psychológia a patopsych. dieťaťa Kovove Materialy-Metallic Materials Slovenská hudbaWebshop Cart
Your Cart is currently empty.
Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.
2020
Significance of transcriptionally-active high-risk human papillomavirus in sinonasal squamous cell carcinoma: Case series and a meta-analysis |
Authors: M. ŠVAJDLER, J. NĚMCOVA, P. DUBINSKÝ, A. METELKOVA, P. ŠVAJDLER, Ľ. STRAKA, R. SAKAŘ, O. DAUM, M. MICHAL, A. SKÁLOVÁ, R. MEZENCEV |
Neoplasma Vol.67, No.6, p.1456–1463, 2020 |
doi:10.4149/neo_2020_200330N332 |
[View Abstract] |
Adjuvant radiotherapy treatment for soft tissue sarcoma of extremities and trunk. A retrospective mono-institutional analysis |
Authors: R. SPOTO, A. VAVASSORI, S. DICUONZO, M. PEPA, S. VOLPE, O. ALESSANDRO, S. GANDINI, B. DI VENOSA, E. MIGLIETTA, C. FODOR, G. M. ORSOLINI, P. PRESTIANNI, F. CATTANI, S. COMI, R. LAZZARI, G. RENNE, T. DE PAS, R. ORECCHIA, E. PENNACCHIOLI, B. A. JERECZEK-FOSSA |
Neoplasma Vol.67, No.6, p.1447–1455, 2020 |
doi:10.4149/neo_2020_200325N305 |
[View Abstract] |
Association of quantitative MRI-based radiomic features with prognostic factors and recurrence rate in oropharyngeal squamous cell carcinoma |
Authors: C. GIANNITTO, G. MARVASO, F. BOTTA, S. RAIMONDI, D. ALTERIO, D. CIARDO, S. VOLPE, F. DE PIANO, E. ANCONA, M. TAGLIABUE, D. ORIGGI, S. CHIOCCA, F. A. MAFFINI, M. ANSARIN, V. BAGNARDI, F. CATTANI, F. NOLÈ, L. PREDA, R. ORECCHIA, E. CASSANO, M. CREMONESI, A. STARZYŃSKA, M. BELLOMI, B. A. JERECZEK-FOSSA |
Neoplasma Vol.67, No.6, p.1437–1446, 2020 |
doi:10.4149/neo_2020_200310N249 |
[View Abstract] |
The efficacy and safety of autologous stem cell transplantation in relapsed chemosensitive and chemoresistant patients with diffuse large B-cell lymphoma |
Authors: A. ARMATYS, A. WIECZORKIEWICZ-KABUT, M. PANZ-KLAPUCH, A. KOCLEGA, A. J. KOPINSKA, D. KATA, K. WOZNICZKA, G. HELBIG |
Neoplasma Vol.67, No.6, p.1431–1436, 2020 |
doi:10.4149/neo_2020_200303N224 |
[View Abstract] |
Insights from the Greek experience of the use of Blinatumomab in pediatric relapsed and refractory acute lymphoblastic leukemia patients |
Authors: Μ. ΑMPATZIDOU, A. KATTAMIS, M. BAKA, G. PATERAKIS, T. ANASTASIOU, M. TZANOUDAKI, A. KAISARI, G. AVGERINOU, D. DOGANIS, V. PAPADAKIS, V. KITRA, S. POLYCHRONOPOULOU |
Neoplasma Vol.67, No.6, p.1424–1430, 2020 |
doi:10.4149/neo_2020_200128N93 |
[View Abstract] |
Gastrointestinal stromal tumors and second primary malignancies: a retrospective monocentric analysis |
Authors: D. COMANDINI, M. GRASSI, A. PRELAJ, V. MARTELLI, A. DAMIANI, G. DAMIANO, S. E. REBUZZI |
Neoplasma Vol.67, No.6, p.1416–1423, 2020 |
doi:10.4149/neo_2020_200301N212 |
[View Abstract] |
Comparison of the efficacy and safety of the EC-T (epirubicin/cyclophosphamide followed by docetaxel) and TCb (docetaxel/carboplatin) neoadjuvant regimens in early TOP2A-normal stage II-III breast cancer. |
Authors: W.P. LI, T. ZHU, M.X. HU, M. YANG, F. JI, H. F. GAO, C. Q. YANG, L. L. ZHANG, M. Y. CHENG, F. P. XU, K. WANG |
Neoplasma Vol.67, No.6, p.1409–1415, 2020 |
doi:10.4149/neo_2020_200130N96 |
[View Abstract] |
Objective response of first-line chemotherapy of triple-negative breast cancer translates into survival benefit: an analysis in an independent, prospective clinical trial and a real-world setting |
Authors: T. LI, Y. H. ZHU, J. ZHANG, B. Y. WANG, S. ZHANG, L. P. WANG, J. CAO, Z. H. TAO, J. XIE, X. C. HU |
Neoplasma Vol.67, No.6, p.1400–1408, 2020 |
doi:10.4149/neo_2020_200225N182 |
[View Abstract] |
Etiology of candidemia in patients with solid tumors - 7 years of experience of one oncology center |
Authors: M. SZYMANKIEWICZ, T. NOWIKIEWICZ |
Neoplasma Vol.67, No.6, p.1391–1399, 2020 |
doi:10.4149/neo_2020_200204N105 |
[View Abstract] |
Third-line treatment for metastatic colorectal cancer: anlotinib is superior to chemotherapy and similar to fruquintinib or regorafenib |
Authors: Y. CHENG, F. C. DU, F. Q. FANG, Z. J. DUAN, W. LEI, K. G. SHI |
Neoplasma Vol.67, No.6, p.1384–1390, 2020 |
doi:10.4149/neo_2020_191125N1212 |
[View Abstract] |
Association of triple positivity with prognostic parameters and overall survival in a population-based study of 6,122 HER2-positive breast cancer patients: analysis of real-world clinical practice based on a research database |
Authors: I. KOLAROVA, J. VANASEK, M. DOLEZEL, J. STUK, A. HLAVKA, L. DUSEK, B. MELICHAR, T. BÜCHLE, A. RYSKA, J. PRAUSOVA, K. PETRAKOVA, P. TESAROVA, J. PETERA, M. VOSMIK, K. HORACKOVA, J. JARKOVSKY |
Neoplasma Vol.67, No.6, p.1373–1383, 2020 |
doi:10.4149/neo_2020_191023N1080 |
[View Abstract] |
Quantitative analysis of 2-hydroxyglutarate as a controversial oncometabolite in malignant gliomas. |
Authors: P. BYSTRICKÝ, I. KAŠUBOVÁ, R. RICHTEROVÁ, Z. LASABOVÁ, B. KOLAROVSZKI |
Neoplasma Vol.67, No.6, p.1367–1372, 2020 |
doi:10.4149/neo_2020_200302N216 |
[View Abstract] |
The loss of PTEN expression and microsatellite stability (MSS) were predictors of unfavorable prognosis in gastric cancer (GC) |
Authors: J. P. FAN, J. QIAN, Y. J. ZHAO |
Neoplasma Vol.67, No.6, p.1359–1366, 2020 |
doi:10.4149/neo_2020_200422N427 |
[View Abstract] |
Novel spectroscopic biomarkers are applicable in non-invasive early detection and staging classification of colorectal cancer |
Authors: M. MISKOVICOVA, V. FRYBA, L. PETRUZELKA, V. SETNICKA, A. SYNYTSYA, M. TATARKOVIC, J. ULRYCH, M. VOCKA |
Neoplasma Vol.67, No.6, p.1349–1358, 2020 |
doi:10.4149/neo_2020_200506N494 |
[View Abstract] |
Identification of large deletions in the APC gene in Russian patients with familial adenomatous polyposis |
Authors: A. S. TSUKANOV, V. V. ZABNENKOVA, V. P. SHUBIN, D. Y. PIKUNOV, T. A. SAVELYEVA, A. M. KUZMINOV, S. A. FROLOV, A. V. POLYAKOV, Y. A. SHELYGIN |
Neoplasma Vol.67, No.6, p.1343–1348, 2020 |
doi:10.4149/neo_2020_191230N1351 |
[View Abstract] |
Neuropilin1, a novel independent prognostic factor and therapeutic target in triple-negative breast cancer |
Authors: H. WANG, Y. N. ZHANG, D. Q. XU, J. G. HUANG, D. LV, X. Y. SHI, J. Y. LIU, H. W. REN, Z. X. HAN |
Neoplasma Vol.67, No.6, p.1335–1342, 2020 |
doi:10.4149/neo_2020_191127N1223 |
[View Abstract] |
Targeted axillary dissection with preoperative tattooing of biopsied positive axillary lymph nodes in breast cancer |
Authors: J. GATEK, V. PETRU, P. KOSAC, M. RATAJSKY, J. DUBEN, B. DUDESEK, P. JANCIK, M. ZABOJNIKOVA, J. KATRUSAK, P. OPELOVA, L. PODRAZSKA, P. VAZAN, P. KUDLOVA, P. HOLIK, B. MELICHAR, D. VRANA |
Neoplasma Vol.67, No.6, p.1329–1334, 2020 |
doi:10.4149/neo_2020_191228N1344 |
[View Abstract] |
Correlation of survival length after pancreaticoduodenectomy for pancreatic head adenocarcinoma depending on tumor characteristics detected by means of computed tomography and resection margins status |
Authors: V. PROCHAZKA, J. HLAVSA, L. KUNOVSKY, M. FARKASOVA, M. POTRUSIL, T. ANDRASINA, A. LITAVCOVA, J. MAZANEC, J. DOLINA, L. OSTRIZKOVA, M. EID, P. KOVALCIKOVA, T. PAVLIK, Z. KALA |
Neoplasma Vol.67, No.6, p.1319–1328, 2020 |
doi:10.4149/neo_2020_190923N955 |
[View Abstract] |
Plasma exosomal miR-125a-5p and miR-141-5p as non-invasive biomarkers for prostate cancer |
Authors: W. LI, Y. DONG, K. J. WANG, Z. DENG, W. ZHANG, H. F. SHEN |
Neoplasma Vol.67, No.6, p.1314–1318, 2020 |
doi:10.4149/neo_2020_191130N1234 |
[View Abstract] |
Lamin B1 deficiency promotes malignancy and predicts poor prognosis in gastric cancer |
Authors: Z. Y. YU, X. Y. JIANG, R. R. ZHAO, C. J. LUO, Y. X. REN, Z. J. MA, H. L. YE, W. G. SHI, C. WANG, Z. Y JIAO |
Neoplasma Vol.67, No.6, p.1303–1313, 2020 |
doi:10.4149/neo_2020_200109N33 |
[View Abstract] |